These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24265390)

  • 1. Comment on: Besser et al. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes. Diabetes Care 2013;36:195-201.
    Chaudhary S; Thukral A; Kataria M; Ghosh S; Mukherjee S; Chowdhury S
    Diabetes Care; 2013 Dec; 36(12):e221. PubMed ID: 24265390
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to comment on: Besser et al. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes. Diabetes Care 2013;36:195-201.
    Shields BM; Henley W; Besser RE; Hattersley AT; Ludvigsson J
    Diabetes Care; 2013 Dec; 36(12):e222. PubMed ID: 24265391
    [No Abstract]   [Full Text] [Related]  

  • 3. Lessons from the mixed-meal tolerance test: use of 90-minute and fasting C-peptide in pediatric diabetes.
    Besser RE; Shields BM; Casas R; Hattersley AT; Ludvigsson J
    Diabetes Care; 2013 Feb; 36(2):195-201. PubMed ID: 23111058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Laboratory Testing in Differentiating Type 1 Diabetes from Type 2 Diabetes in Patients Undergoing Bariatric Surgery.
    Pilla SJ; Maruthur NM; Schweitzer MA; Magnuson TH; Potter JJ; Clark JM; Lee CJ
    Obes Surg; 2018 Jan; 28(1):25-30. PubMed ID: 28695457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting C-peptide and Related Parameters Characterizing Insulin Secretory Capacity for Correctly Classifying Diabetes Type and for Predicting Insulin Requirement in Patients with Type 2 Diabetes.
    Becht FS; Walther K; Martin E; Nauck MA
    Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):148-56. PubMed ID: 26824281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic tests to determine risk for type 1 diabetes in clinical trials.
    Greenbaum CJ; Buckingham B; Chase HP; Krischer J;
    Diabetes Metab Res Rev; 2011 Sep; 27(6):584-9. PubMed ID: 21488143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of C-peptide.
    Rubenstein AH; Gonen B
    Adv Exp Med Biol; 1979; 124():15-28. PubMed ID: 506831
    [No Abstract]   [Full Text] [Related]  

  • 8. Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes.
    Pham MN; Kolb H; Battelino T; Ludvigsson J; Pozzilli P; Zivehe F; Roden M; Mandrup-Poulsen T; Schloot NC;
    Diabetologia; 2013 Jun; 56(6):1356-63. PubMed ID: 23494449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: A comparison of classification schemes for ketosis-prone diabetes.
    Nalini R; Maldonado M; Balasubramanyam A
    Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):E1. PubMed ID: 18026157
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors Related to Blood Intact Incretin Levels in Patients with Type 2 Diabetes Mellitus.
    Yoo S; Yang EJ; Koh G
    Diabetes Metab J; 2019 Aug; 43(4):495-503. PubMed ID: 30877705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-peptide response to glucagon injections in IDDM and NIDDM patients.
    Poulsen S; Billesbølle P; Kølendorf K; Thorsteinsson B
    Horm Metab Res; 1985 Jan; 17(1):39-40. PubMed ID: 3967844
    [No Abstract]   [Full Text] [Related]  

  • 12. The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes.
    Greenbaum C; Seidel K; Pihoker C
    Diabetes Care; 2004 May; 27(5):1202-4. PubMed ID: 15111546
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients.
    Furuta M; Tamai M; Hanabusa T; Yamamoto Y; Nanjo K; Sanke T
    Diabetes Res Clin Pract; 2006 Jun; 72(3):302-7. PubMed ID: 16442181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes.
    Sims EK; Chaudhry Z; Watkins R; Syed F; Blum J; Ouyang F; Perkins SM; Mirmira RG; Sosenko J; DiMeglio LA; Evans-Molina C
    Diabetes Care; 2016 Sep; 39(9):1519-26. PubMed ID: 27385327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1.
    Sosenko JM; Geyer S; Skyler JS; Rafkin LE; Ismail HM; Libman IM; Liu YF; DiMeglio LA; Evans-Molina C; Palmer JP
    Pediatr Diabetes; 2018 May; 19(3):403-409. PubMed ID: 29171129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus].
    Perusicová J; Bárová H; Hill M; Masek Z
    Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis.
    Evans-Molina C; Sims EK; DiMeglio LA; Ismail HM; Steck AK; Palmer JP; Krischer JP; Geyer S; Xu P; Sosenko JM;
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of the glucagon test depends upon the prevailing blood glucose concentration in type I (insulin-dependent) diabetic patients.
    Madsbad S; Sauerbrey N; Møller-Jensen B; Krarup T; Kühl C
    Acta Med Scand; 1987; 222(1):71-4. PubMed ID: 3630779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum C-peptide content in nutritional diabetes.
    Ahuja MM; Sharma GP
    Horm Metab Res; 1985 May; 17(5):267-8. PubMed ID: 4007780
    [No Abstract]   [Full Text] [Related]  

  • 20. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.
    Greenbaum CJ; Mandrup-Poulsen T; McGee PF; Battelino T; Haastert B; Ludvigsson J; Pozzilli P; Lachin JM; Kolb H; ;
    Diabetes Care; 2008 Oct; 31(10):1966-71. PubMed ID: 18628574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.